12 completed, 7 unknown, 3 terminated, 2 withdrawn. 26 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 26 | Completed 12, Unknown 7, Terminated 3, Withdrawn 2, Recruiting 1, Suspended 1 |
| Phase 2 | 9 | Completed 3, Unknown 3, Withdrawn 2, Terminated 1 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) Brenzavvy (bexagliflozin), 20 mg Oral Tablet, Placebo - Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease | Phase 1 | Recruiting | University of Virginia | 150 | 2025-07-15 | 2026-09-09 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease AlloRx - Congestive Heart Failure, Angina | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 3 | 2022-02-01 | 2026-10-20 |
| Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) AdVEGFXC1 - Coronary Artery Disease, Ischemia | Phase 1 / Phase 2 | Completed | XyloCor Therapeutics, Inc. | 41 | 2020-01-24 | 2024-01-30 |
| Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers D935 Cap. 1T, CKD-385 Tab. 1T - Hypertension | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 52 | 2018-10-24 | 2018-12-31 |
| Citalopram for Sx/Util in Acute Coronary Syndrome Patients Citalopram - Acute Coronary Syndrome | Phase 1 / Phase 2 | Withdrawn | Henry Ford Health System | 2016-01-01 | 2022-12-09 | |
| Hierarchical Treatment Based on Somatization Symptom Checklist Deanxit, Prozac, coronary artery disease treatment - Syndrome X | Phase 1 / Phase 2 | Unknown | RenJi Hospital | 200 | 2015-12-01 | 2020-03-04 |
| Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy UCMSC group - Chronic Ischemic Heart Disease, Heart Failure | Phase 1 / Phase 2 | Unknown | Affiliated Hospital to Academy of Military Medical Sciences | 40 | 2015-05-01 | 2016-03-16 |
| Gene Therapy for the Treatment of Chronic Stable Angina VM202 - Myocardial Ischemia | Phase 1 / Phase 2 | Withdrawn | Helixmith Co., Ltd. | 2015-03-01 | 2025-09-25 | |
| Cardioprotective Effects of GLP-1 and Their Mechanisms GLP-1 (7-36) amide, Glibenclamide - Angina Pectoris | Phase 1 | Completed | Papworth Hospital NHS Foundation Trust | 32 | 2014-07-01 | 2016-04-11 |
| Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg Dilatrend SR capsule 32mg, Dilatrend IR tablet 25mg - Essential Hypertension, Chronic Stable Angina | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 48 | 2013-04-01 | 2013-04-01 |
| A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers Dilatrend 64mg capsule - Chronic Stable Angina | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2011-07-01 | 2011-12-22 |
| Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule Dilatrend SR capsule - Chronic Stable Angina | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2011-06-01 | 2012-02-15 |
| A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes T89(Dantonic) - Stable Angina | Phase 1 | Completed | Tasly Pharmaceuticals, Inc. | 24 | 2011-01-01 | 2012-11-08 |
| Adenosine Cardioplegia; Improved Cardioprotection? Adenosine - Angina Pectoris | Phase 1 / Phase 2 | Completed | University Hospital of North Norway | 60 | 2010-04-01 | 2011-09-30 |
| EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease VEGF-D gene transfer - Angina Pectoris, Myocardial Infarction | Phase 1 | Completed | Kuopio University Hospital | 30 | 2010-01-10 | 2018-03-08 |
| Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes clopidogrel, prasugrel - Acute Coronary Syndromes | Phase 1 | Terminated | Eli Lilly and Company | 29 | 2009-10-01 | 2012-03-09 |
| Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec) - Refractory Angina Pectoris | Phase 1 | Suspended | Medispec | 20 | 2009-03-01 | 2012-04-03 |
| Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec) - Refractory Angina Pectoris | Phase 1 | Completed | Medispec | 33 | 2009-01-01 | 2013-02-20 |
| Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis Selected CD 133+ cells - Coronary Artery Disease, Refractory Angina | Phase 1 / Phase 2 | Completed | Pilar Jimenez Quevedo | 28 | 2008-05-01 | 2013-08-06 |
| A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) telcagepant, Placebo to telcagepant - Angina Pectoris, Coronary Heart Disease | Phase 1 | Completed | Merck Sharp & Dohme LLC | 64 | 2008-02-12 | 2018-10-18 |
Showing 20 of 26. Sign in to see all of them.
Myocardial Ischemia (7) · Angina, Stable (6) · Heart Failure (5) · Coronary Artery Disease (4) · Chest Pain (3) · Heart Diseases (3) · Acute Coronary Syndrome (2) · Coronary Disease (2) · Hypertension (2) · Ischemia (2) · Microvascular Angina (2) · Myocardial Infarction (2) · Cardiovascular Diseases (1) · Essential Hypertension (1)
Cardiovascular Diseases (25) · Neurologic Manifestations (25) · Pathological Conditions, Signs and Symptoms (25) · Signs and Symptoms (25) · Vascular Diseases (25) · Pain (24) · Heart Diseases (23) · Chest Pain (22) · Myocardial Ischemia (19) · Pathologic Processes (5) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Coronary Disease (3) · Infarction (2)
Carvedilol (2) · Adenosine (1) · Atenolol (1) · Citalopram (1) · Clopidogrel (1) · D 935 (1) · Fluoxetine (1) · Glyburide (1) · Prasugrel Hydrochloride (1) · T89 herbal drug (1) · Tablets (1) · bexagliflozin (1) · flupentixol, melitracen drug combination (1) · glucagon-like peptide 1 (7-36)amide (1) · telcagepant (1)
Chong Kun Dang Pharmaceutical (4) · Medispec (3) · Affiliated Hospital to Academy of Military Medical Sciences (1) · Eli Lilly and Company (1) · Foundation for Biomedical Research and Innovation (1) · Helixmith Co., Ltd. (1) · Henry Ford Health System (1) · Kuopio University Hospital (1) · Losordo, Douglas, M.D. (1) · Merck Sharp & Dohme LLC (1) · Papworth Hospital NHS Foundation Trust (1) · Pilar Jimenez Quevedo (1) · RenJi Hospital (1) · Sandoz (1) · Tasly Pharmaceuticals, Inc. (1)
United States (6) · South Korea (4) · Canada (2) · China (2) · Germany (2) · Antigua and Barbuda (1) · Argentina (1) · Finland (1) · Israel (1) · Japan (1) · Netherlands (1) · Norway (1) · Spain (1) · United Kingdom (1)
Arvi Grover, MD (1) · Bing Liu, M.D (1) · Chadwick Prodromos, MD (1) · Dan Tzivoni, MD (1) · Judy H Watt-Watson, PhD (1) · Juha Hartikainen (1) · KS Bae, Ph.D (1) · Kyung-Ho Jang (1) · Lothar Faber, Prof. MD (1) · Mao Jialiang, Docter (1) · Mark W Ketterer, PhD (1) · Michael H McGillion, PhD (1)
PMID 17562958, PMID 22278333, PMID 22372531, PMID 22964356, PMID 27431258, PMID 34224684, PMID 35750637, PMID 37503661, PMID 38696284
2008 (1)